- cafead Jun 06, 2023 at 04:22: PM
via The biotech will get another chance to make a case for its drug NurOwn during a Sept. 27 meeting of cell, tissue and gene therapy experts.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
FDA sets advisory meeting date for Brainstorm’s ALS cell therapy
- Thread starter cafead
- Start date
<
Similar threads